FEMY
Femasys Inc.
There isn't enough reported data to score FEMY yet.
FEMY Fundamentals
| Metric | Status |
|---|---|
| Stable | |
| Under pressure | |
| Weak | |
| Unavailable |
FEMY's revenue is currently stable, but its profitability and cash flow are under pressure. There isn't enough data to rate its balance sheet.
FEMY PE Valuation
FEMY has no meaningful PE right now: it lost money over the past year.
FEMY Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Losses shrinking | |
| Strong growth | |
| -- | |
| Limited | |
| Low |
Analysts expect FEMY's losses to shrink, with revenue growing. However, they disagree widely on these estimates.
FEMY Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q3 2025 | -$14.40 | +$2.00 |
| Q2 2025 | -$17.20 | -$0.40 |
| Q1 2025 | -$18.20 | -$1.20 |
| Q4 2024 | -$17.00 | +$1.60 |
| Q3 2024 | -$16.40 | +$3.20 |
| Q2 2024 | -$16.80 | +$2.60 |
| Q1 2024 | -$17.00 | +$2.40 |
| Q4 2023 | -$18.60 | +$0.60 |
FEMY is still losing money, but less than at its worst: $14.40 per share over the past year, against $21.00 at its worst in late 2021.
FEMY Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q2 2026 | $331.8K | -19% |
| Q1 2026 | $424.9K | +25% |
| Q4 2025 | $813.4K | +40% |
| Q3 2025 | $729.4K | +31% |
| Q2 2025 | $409.3K | +85% |
| Q1 2025 | $341.3K | +26% |
| Q4 2024 | $581.6K | +173% |
| Q3 2024 | $554.9K | +127% |
FEMY's revenue is growing: $331,827 last quarter, down 19% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q2 2026 | -1527% | -586 points |
| Q1 2026 | -994% | +606 points |
| Q4 2025 | -568% | +244 points |
| Q3 2025 | -501% | +422 points |
| Q2 2025 | -941% | +1083 points |
| Q1 2025 | -1600% | -323 points |
| Q4 2024 | -812% | +1276 points |
| Q3 2024 | -922% | +748 points |
FEMY's operating margin was −1527% last quarter, down 586 points from the same quarter a year ago.
FEMY Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q2 2026 | -$3.9M | +$501.9K |
| Q1 2026 | -$4.2M | +$639.2K |
| Q4 2025 | -$4.3M | +$856.3K |
| Q3 2025 | -$5.6M | +$300.9K |
| Q2 2025 | -$4.4M | +$62.1K |
| Q1 2025 | -$4.9M | -$229.1K |
| Q4 2024 | -$5.2M | -$2.1M |
| Q3 2024 | -$5.9M | -$3M |
FEMY has burned cash in almost every quarter: −$18M over the past year, against −$20M the year before.
FEMY Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -14% | -548K shares |
| 1 year | +167% | +2.1M shares |
| 3 years | +468% | +2.8M shares |
| 5 years | +637% | +2.9M shares |
FEMY has 3M diluted shares, up 167% from a year ago.
| Quarter | Spent |
|---|---|
| Q1 2025 | $161,761 |
| Q4 2024 | $30,093 |
| Q3 2024 | — |
| Q2 2024 | $6,593 |
| Q1 2024 | $24,067 |
| Q1 2021 | — |
| Q4 2020 | — |
| Q3 2020 | — |
FEMY Net Leverage
FEMY's operating earnings (EBITDA) were negative over the past year, so its debt can't be measured against them.
FEMY Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 28.7 | Oversold |
| Stochastic | 4.5 | Oversold |
FEMY's weekly RSI is 29 (oversold) and its Stochastic is 5 (oversold).
FEMY PE vs Healthcare Sector
FEMY has no meaningful PE right now: it lost money over the past year.
FEMY Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $1.73 | 19% below |
| 20 week MA | $2.55 | 45% below |
| 50 week MA | $7.09 | 80% below |
| 100 week MA | $13.3 | 89% below |
| 200 week MA | $17.3 | 92% below |
FEMY is in a downtrend: it's below all five of its weekly moving averages, and 92% below its 200-week average.
FEMY Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2021 | $240.0 | $91.6 | -62% |
| 2022 | $91.6 | $18.6 | -80% |
| 2023 | $18.6 | $19.5 | +4.8% |
| 2024 | $19.5 | $22.6 | +16% |
| 2025 | $22.6 | $14.2 | -37% |
| 2026 YTD | $14.2 | $1.40 | -90% |
FEMY has finished lower in three of the last five years. It's down 90% so far in 2026.